MUMBAI, June 11 (Reuters) – India’s No. 2 drugmaker Dr
Reddy’s Laboratories Ltd said it agreed to buy a
portfolio of eight generic drugs from Teva Pharmaceutical
Industries Ltd and Allergan Plc for…
The post India’s Dr Reddy’s to buy 8 U.S. generic drugs from Teva, Allergan for $350 mln appeared first on NASDAQ.